CALLA trial: immunotherapy in locally advanced cervical cancer - Authors' reply

Lancet Oncol. 2024 Mar;25(3):e96. doi: 10.1016/S1470-2045(24)00098-6.
No abstract available

Publication types

  • Letter

MeSH terms

  • Clinical Trials as Topic
  • Female
  • Humans
  • Immunotherapy / adverse effects
  • Uterine Cervical Neoplasms* / therapy